학술논문
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Document Type
Article
Author
Souers, A.J.; Leverson, J.D.; Boghaert, E.R.; Ackler, S.L.; Catron, N.D.; Chen, J.; Dayton, B.D.; Ding, H.; Enschede, S.H.; Jin, S.; Kovar, P.J.; Lam, L.T.; Marsh, K.C.; Mitten, M.J.; Nimmer, P.M.; Oleksijew, A.; Park, C.H.; Park, C.-M.; Phillips, D.C.; Smith, M.L.; Sullivan, G.M.; Tahir, S.K.; Tse, C.; Wendt, M.D.; Xiao, Y.; Xue, J.C.; Zhang, H.; Humerickhouse, R.A.; Rosenberg, S.H.; Elmore, S.W.; Fairbrother, W.J.; Hymowitz, S.G.; Lee, J.; Maecker, H.L.; Sampath, D.; Huang, D.C.S.; Khaw, S.L.; Mason, K.D.; Roberts, A.W.; Seymour, J.F.
Source
In: Nature Medicine . (Nature Medicine, February 2013, 19(2):202-208)
Subject
Language
English
ISSN
10788956
1546170X
1546170X